相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2010 Clinical Trial/Clinical Science Abstracts
CIRCULATION (2010)
Confiscated Black Market Products and Nutritional Supplements with Non-Approved Ingredients Analyzed in the Cologne Doping Control Laboratory 2009
Maxie Kohler et al.
DRUG TESTING AND ANALYSIS (2010)
Detection of His-tagged Long-R3-IGF-I in a black market product
Maxie Kohler et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration
Ye-Rang Yun et al.
Journal of Tissue Engineering (2010)
Increased Protein Stability of FGF1 Can Compensate for Its Reduced Affinity for Heparin
Malgorzata Zakrzewska et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Emerging drugs: mechanism of action, mass spectrometry and doping control analysis
Mario Thevis et al.
JOURNAL OF MASS SPECTROMETRY (2009)
Growth factor delivery methods in the management of sports injuries: the state of play
L. Creaney et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2008)
FGF-1: From Biology Through Engineering to Potential Medical Applications
Malgorzata Zakrzewska et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2008)
Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia
Sigrid Nikol et al.
MOLECULAR THERAPY (2008)
Functions and regulations of fibroblast growth factor signaling during embryonic development
B Thisse et al.
DEVELOPMENTAL BIOLOGY (2005)
Design of fully active FGF-1 variants with increased stability
M Zakrzewska et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Fibroblast growth factor 1 - A key regulator of human adipogenesis
L Hutley et al.
DIABETES (2004)
Thermodynamic characterization of mutants of human fibroblast growth factor 1 with an increased physiological half-life
JF Culajay et al.
BIOCHEMISTRY (2000)
分享论文
